Express News | Theriva Biologics Inc Files for Offering up to 7.7 Mln Shares and Warrants

ReutersDec 10 17:23 ET

Express News | Theriva Biologics Inc - to Request Additional FDA Meeting After Virage Study Completion

ReutersDec 5 08:00 ET

Express News | Theriva Biologics Inc: FDA Advised That on-Going Virage Phase 2B Study Should Not Be Expanded Into a Phase 3 Study

ReutersDec 5 08:00 ET

Theriva Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of VCN-01 for the Treatment of Metastatic Pancreatic Cancer

GlobeNewswireDec 5 08:00 ET

Express News | Theriva™ Biologics Announces U.S. FDA Guidance on Design of Phase 3 Study of Vcn-01 for the Treatment of Metastatic Pancreatic Cancer

ReutersDec 5 08:00 ET

Theriva Biologics Highlights Key Achievements in Q3 2024

TipRanksNov 13 23:50 ET